225 related articles for article (PubMed ID: 10556281)
1. Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9.
Niksic M; Romano M; Buratti E; Pagani F; Baralle FE
Hum Mol Genet; 1999 Dec; 8(13):2339-49. PubMed ID: 10556281
[TBL] [Abstract][Full Text] [Related]
2. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element.
Pagani F; Buratti E; Stuani C; Romano M; Zuccato E; Niksic M; Giglio L; Faraguna D; Baralle FE
J Biol Chem; 2000 Jul; 275(28):21041-7. PubMed ID: 10766763
[TBL] [Abstract][Full Text] [Related]
3. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing.
Zuccato E; Buratti E; Stuani C; Baralle FE; Pagani F
J Biol Chem; 2004 Apr; 279(17):16980-8. PubMed ID: 14966131
[TBL] [Abstract][Full Text] [Related]
4. Atypical 5' splice sites cause CFTR exon 9 to be vulnerable to skipping.
Hefferon TW; Broackes-Carter FC; Harris A; Cutting GR
Am J Hum Genet; 2002 Aug; 71(2):294-303. PubMed ID: 12068373
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing of intron 23 of the human cystic fibrosis transmembrane conductance regulator gene resulting in a novel exon and transcript coding for a shortened intracytoplasmic C terminus.
Yoshimura K; Chu CS; Crystal RG
J Biol Chem; 1993 Jan; 268(1):686-90. PubMed ID: 7678008
[TBL] [Abstract][Full Text] [Related]
6. Cis-acting intronic elements that regulate cartilage-specific alternative splicing of the type II collagen (Col2) pre-mRNA lie at or near splice site junction sequences flanking exon 2 of the gene.
Nishiyama T; Hatano H; Kurosaka M; Bolander ME; Sarkar G
J Bone Miner Res; 2003 Sep; 18(9):1716-22. PubMed ID: 12968682
[TBL] [Abstract][Full Text] [Related]
7. Promoter architecture modulates CFTR exon 9 skipping.
Pagani F; Stuani C; Zuccato E; Kornblihtt AR; Baralle FE
J Biol Chem; 2003 Jan; 278(3):1511-7. PubMed ID: 12421814
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.
Buratti E; Dörk T; Zuccato E; Pagani F; Romano M; Baralle FE
EMBO J; 2001 Apr; 20(7):1774-84. PubMed ID: 11285240
[TBL] [Abstract][Full Text] [Related]
9. Multiple cis elements regulate an alternative splicing event at 4.1R pre-mRNA during erythroid differentiation.
Deguillien M; Huang SC; Morinière M; Dreumont N; Benz EJ; Baklouti F
Blood; 2001 Dec; 98(13):3809-16. PubMed ID: 11739190
[TBL] [Abstract][Full Text] [Related]
10. A T3 allele in the CFTR gene exacerbates exon 9 skipping in vas deferens and epididymal cell lines and is associated with Congenital Bilateral Absence of Vas Deferens (CBAVD).
Disset A; Michot C; Harris A; Buratti E; Claustres M; Tuffery-Giraud S
Hum Mutat; 2005 Jan; 25(1):72-81. PubMed ID: 15580565
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing of the ovine CFTR gene.
Broackes-Carter FC; Williams SH; Wong PL; Mouchel N; Harris A
Mamm Genome; 2003 Nov; 14(11):778-87. PubMed ID: 14722727
[TBL] [Abstract][Full Text] [Related]
12. In NF1, CFTR, PER3, CARS and SYT7, alternatively included exons show higher conservation of surrounding intron sequences than constitutive exons.
Kaufmann D; Kenner O; Nurnberg P; Vogel W; Bartelt B
Eur J Hum Genet; 2004 Feb; 12(2):139-49. PubMed ID: 14560314
[TBL] [Abstract][Full Text] [Related]
13. An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects.
Fernandez Alanis E; Pinotti M; Dal Mas A; Balestra D; Cavallari N; Rogalska ME; Bernardi F; Pagani F
Hum Mol Genet; 2012 Jun; 21(11):2389-98. PubMed ID: 22362925
[TBL] [Abstract][Full Text] [Related]
14. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles.
Steiner B; Truninger K; Sanz J; Schaller A; Gallati S
Hum Mutat; 2004 Aug; 24(2):120-9. PubMed ID: 15241793
[TBL] [Abstract][Full Text] [Related]
15. CELF proteins regulate CFTR pre-mRNA splicing: essential role of the divergent domain of ETR-3.
Dujardin G; Buratti E; Charlet-Berguerand N; Martins de Araujo M; Mbopda A; Le Jossic-Corcos C; Pagani F; Ferec C; Corcos L
Nucleic Acids Res; 2010 Nov; 38(20):7273-85. PubMed ID: 20631008
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a disease-associated mutation affecting a putative splicing regulatory element in intron 6b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
Faà V; Incani F; Meloni A; Corda D; Masala M; Baffico AM; Seia M; Cao A; Rosatelli MC
J Biol Chem; 2009 Oct; 284(44):30024-31. PubMed ID: 19759008
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing of protein 4.1R exon 16: ordered excision of flanking introns ensures proper splice site choice.
Gee SL; Aoyagi K; Lersch R; Hou V; Wu M; Conboy JG
Blood; 2000 Jan; 95(2):692-9. PubMed ID: 10627481
[TBL] [Abstract][Full Text] [Related]
18. Molecular study of (TG)m(T)n polymorphisms in Iranian males with congenital bilateral absence of the vas deferens.
Radpour R; Gourabi H; Gilani MA; Dizaj AV
J Androl; 2007; 28(4):541-7. PubMed ID: 17314234
[TBL] [Abstract][Full Text] [Related]
19. Novel mutation c.1210-3C > G in cis with a poly-T tract of 5T affects CFTR mRNA splicing in a Chinese patient with cystic fibrosis.
Zhao X; Liu K; Xu W; Xiao M; Zhang Q; Song J; Chen K; Liu Y; Tian X; Xu KF; Zhang X
Front Med; 2022 Feb; 16(1):150-155. PubMed ID: 34302615
[TBL] [Abstract][Full Text] [Related]
20. SR protein-mediated inhibition of CFTR exon 9 inclusion: molecular characterization of the intronic splicing silencer.
Buratti E; Stuani C; De Prato G; Baralle FE
Nucleic Acids Res; 2007; 35(13):4359-68. PubMed ID: 17576688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
